Literature DB >> 8984938

Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?

J N Stolk1, A M Boerbooms, R A De Abreu, P J Kerstens, D G de Koning, R de Graaf, J Mulder, L B van de Putte.   

Abstract

OBJECTIVE: Purine enzyme activities may predict the effectiveness of azathioprine treatment and be associated with increased deaths from infectious diseases. In rheumatoid arthritis, patients show variable responses to azathioprine and a higher percentage of death is caused by infections. The aim of the study was to investigate possible rheumatoid arthritis associated abnormalities of purine enzyme activities by measuring several of these enzymes in patients with recent onset rheumatoid arthritis before treatment with disease modifying antirheumatic drugs or prednisone.
METHODS: 23 patients with recent onset rheumatoid arthritis and 28 healthy controls were studied. Activities of the enzymes 5'-nucleotidase, purine nucleoside phosphorylase (PNP), hypoxanthine guanine phosphoribosyltransferase (HGPRT), and thiopurine methyltransferase (TPMT) were measured. Assessment of disease activity and blood sampling for routine measurements and HLA typing were done simultaneously.
RESULTS: Purine enzyme activities did not differ between patients and healthy controls. Enzyme activities had no significant relations with indices of disease activity or rheumatoid factor titre or with the rheumatoid arthritis associated HLA types. Activity of 5'nucleotidase decreased with age (P < or = 0.05) and was lower by about 27% (P = 0.007) in males than in females.
CONCLUSIONS: In rheumatoid arthritis patients, neither the variability in azathioprine effectiveness nor the increased death rate from infections can be explained by pre-existing abnormalities in the activities of the purine enzymes 5'-nucleotidase, PNP, HGPRT, or TPMT at an early stage of the disease, before disease modifying antirheumatic drugs or prednisone treatment. Besides adjustment for age, results of studies involving purine 5' nucleotidase activity should also be adjusted for sex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8984938      PMCID: PMC1010291          DOI: 10.1136/ard.55.10.733

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients.

Authors:  P R Chocair; J A Duley; H A Simmonds; J S Cameron
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

2.  Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements.

Authors:  F Hulstaert; I Hannet; V Deneys; V Munhyeshuli; T Reichert; M De Bruyere; K Strauss
Journal:  Clin Immunol Immunopathol       Date:  1994-02

3.  Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia.

Authors:  S M Johnson; M E North; G L Asherson; J Allsop; R W Watts; A D Webster
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

Review 4.  Disease-modifying drugs for progressive rheumatoid arthritis.

Authors:  T W Bunch; J D O'Duffy
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

5.  The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism.

Authors:  W N Kelley; F M Rosenbloom; J E Seegmiller
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

6.  Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.

Authors:  M E Jeurissen; A M Boerbooms; L B van de Putte; M W Kruijsen
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

7.  Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.

Authors:  R M Weinshilboum; F A Raymond; P A Pazmiño
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

Review 8.  Purine nucleoside phosphorylase deficiency.

Authors:  M L Markert
Journal:  Immunodefic Rev       Date:  1991

9.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

10.  Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure.

Authors:  J N Stolk; R A De Abreu; A M Boerbooms; D G de Koning; R de Graaf; P J Kerstens; L B van de Putte
Journal:  J Chromatogr B Biomed Appl       Date:  1995-04-07
View more
  1 in total

1.  Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.

Authors:  A E van Ede; R F J M Laan; R A De Abreu; A B J Stegeman; L B A van de Putte
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.